Bithionol
Star1
Identification
- Generic Name
- Bithionol
- DrugBank Accession Number
- DB04813
- Background
Bithionol, formerly marketed as an active ingredient in various topical drug products, was shown to be a potent photosensitizer with the potential to cause serious skin disorders. Approvals of the NDA's for bithionol drug products were withdrawn on October 24, 1967 (see the Federal Register of October 31, 1967 (32 FR 15046)).
- Type
- Small Molecule
- Groups
- Approved, Withdrawn
- Structure
- Weight
- Average: 356.052
Monoisotopic: 353.884260954 - Chemical Formula
- C12H6Cl4O2S
- Synonyms
- 2-Hydroxy-3,5-dichlorophenyl sulfide
- 2-Hydroxy-3,5-dichlorophenyl sulphide
- 2,2'-Dihydroxy-3,3',5,5'-tetrachlorodiphenyl sulfide
- 2,2'-Dihydroxy-3,3',5,5'-tetrachlorodiphenylsulfide
- 2,2'-sulfanediylbis(4,6-dichlorophenol)
- 2,2'-Thiobis(4,6-dichlorophenol)
- Bis(3,5-dichloro-2-hydroxyphenyl) sulfide
- Bithionol
- Bithionol sulfide
- Bithionolate
- Bithionolum
- Bitionol
- External IDs
- Caswell No. 852
- CP 3438
- USAF B-22
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
- Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API
- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
- Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.
- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs Browse all" title="About SNP Mediated Effects/ADRs" id="snp-actions-info" class="drug-info-popup" href="javascript:void(0);">
- Not Available
Interactions
- Drug Interactions Learn More" title="About Drug Interactions" id="structured-interactions-info" class="drug-info-popup" href="javascript:void(0);">
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Products
- Drug product information from 10+ global regionsOur datasets provide approved product information including:dosage, form, labeller, route of administration, and marketing period.Access drug product information from over 10 global regions.
- Product Ingredients
Ingredient UNII CAS InChI Key Bithionolate sodium 66V0139H9A 6385-58-6 FNYZFZRGBBCWBI-UHFFFAOYSA-L - International/Other Brands
- Actamer / Bidiphen / Bisoxyphen / Bithin / Bitin / Lorothidol / Lorothiodol / Neopellis / Nobacter / Vancide BL
Categories
- ATC Codes
- D10AB01 — Bithionol
- D10AB — Preparations containing sulfur
- D10A — ANTI-ACNE PREPARATIONS FOR TOPICAL USE
- D10 — ANTI-ACNE PREPARATIONS
- D — DERMATOLOGICALS
- Drug Categories
- Anthelmintics
- Anti-Acne Preparations
- Anti-Acne Preparations for Topical Use
- Anti-Infective Agents
- Anti-Infective Agents, Local
- Antiparasitic Agents
- Antiparasitic Products, Insecticides and Repellents
- Antiplatyhelmintic Agents
- Antitrematodals
- Benzene Derivatives
- Dermatologicals
- Phenols
- Preparations Containing Sulfur
- Chemical TaxonomyProvided by Classyfire
- Description
- This compound belongs to the class of organic compounds known as diarylthioethers. These are organosulfur compounds containing a thioether group that is substituted by two aryl groups.
- Kingdom
- Organic compounds
- Super Class
- Organosulfur compounds
- Class
- Thioethers
- Sub Class
- Aryl thioethers
- Direct Parent
- Diarylthioethers
- Alternative Parents
- Thiophenol ethers / P-chlorophenols / O-chlorophenols / Dichlorobenzenes / Aryl chlorides / Sulfenyl compounds / Organooxygen compounds / Organochlorides / Hydrocarbon derivatives
- Substituents
- 1,3-dichlorobenzene / 2-chlorophenol / 2-halophenol / 4-chlorophenol / 4-halophenol / Aromatic homomonocyclic compound / Aryl chloride / Aryl halide / Benzenoid / Chlorobenzene
- Molecular Framework
- Aromatic homomonocyclic compounds
- External Descriptors
- aryl sulfide, polyphenol, dichlorobenzene, organochlorine pesticide, bridged diphenyl fungicide, bridged diphenyl antifungal drug (CHEBI:3131)
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- AMT77LS62O
- CAS number
- 97-18-7
- InChI Key
- JFIOVJDNOJYLKP-UHFFFAOYSA-N
- InChI
- InChI=1S/C12H6Cl4O2S/c13-5-1-7(15)11(17)9(3-5)19-10-4-6(14)2-8(16)12(10)18/h1-4,17-18H
- IUPAC Name
- 2,4-dichloro-6-[(3,5-dichloro-2-hydroxyphenyl)sulfanyl]phenol
- SMILES
- OC1=C(SC2=C(O)C(Cl)=CC(Cl)=C2)C=C(Cl)C=C1Cl
References
- General References
- Not Available
- External Links
- KEGG Drug
- D00802
- KEGG Compound
- C07967
- PubChem Compound
- 2406
- PubChem Substance
- 46508019
- ChemSpider
- 2313
- BindingDB
- 36880
- ChEBI
- 3131
- ChEMBL
- CHEMBL290106
- ZINC
- ZINC000000608213
- Guide to Pharmacology
- GtP Drug Page
- PDBe Ligand
- B1T
- Wikipedia
- Bithionol
- PDB Entries
- 3etd / 5d0r / 7erh
Clinical Trials
- Clinical Trials Learn More" title="About Clinical Trials" id="clinical-trials-info" class="drug-info-popup" href="javascript:void(0);">
Phase Status Purpose Conditions Count
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
- Not Available
- Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Solid
- Experimental Properties
Property Value Source melting point (°C) 188 °C PhysProp water solubility 4 mg/L (at 25 °C) MERCK INDEX (1996) pKa 4.82 MERCK INDEX (1996) - Predicted Properties
Property Value Source Water Solubility 0.00166 mg/mL ALOGPS logP 6.12 ALOGPS logP 5.97 Chemaxon logS -5.3 ALOGPS pKa (Strongest Acidic) 4.89 Chemaxon pKa (Strongest Basic) -7.2 Chemaxon Physiological Charge -1 Chemaxon Hydrogen Acceptor Count 2 Chemaxon Hydrogen Donor Count 2 Chemaxon Polar Surface Area 40.46 Å2 Chemaxon Rotatable Bond Count 2 Chemaxon Refractivity 81.92 m3·mol-1 Chemaxon Polarizability 31.3 Å3 Chemaxon Number of Rings 2 Chemaxon Bioavailability 1 Chemaxon Rule of Five No Chemaxon Ghose Filter No Chemaxon Veber's Rule No Chemaxon MDDR-like Rule No Chemaxon - Predicted ADMET Features
Property Value Probability Human Intestinal Absorption + 0.9909 Blood Brain Barrier + 0.8869 Caco-2 permeable + 0.7873 P-glycoprotein substrate Non-substrate 0.7822 P-glycoprotein inhibitor I Non-inhibitor 0.943 P-glycoprotein inhibitor II Non-inhibitor 0.9609 Renal organic cation transporter Non-inhibitor 0.819 CYP450 2C9 substrate Non-substrate 0.7194 CYP450 2D6 substrate Non-substrate 0.8524 CYP450 3A4 substrate Non-substrate 0.6484 CYP450 1A2 substrate Inhibitor 0.9107 CYP450 2C9 inhibitor Inhibitor 0.9127 CYP450 2D6 inhibitor Non-inhibitor 0.8961 CYP450 2C19 inhibitor Inhibitor 0.8995 CYP450 3A4 inhibitor Non-inhibitor 0.6459 CYP450 inhibitory promiscuity High CYP Inhibitory Promiscuity 0.9131 Ames test Non AMES toxic 0.9133 Carcinogenicity Non-carcinogens 0.733 Biodegradation Not ready biodegradable 0.9922 Rat acute toxicity 3.1921 LD50, mol/kg Not applicable hERG inhibition (predictor I) Weak inhibitor 0.9401 hERG inhibition (predictor II) Non-inhibitor 0.8592
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
Spectrum Spectrum Type Splash Key Predicted MS/MS Spectrum - 10V, Positive (Annotated) Predicted LC-MS/MS splash10-0udi-0309000000-0f3b02346cac8d14ae58 Predicted MS/MS Spectrum - 10V, Negative (Annotated) Predicted LC-MS/MS splash10-0udi-0009000000-c061d6a6d41550c7855c Predicted MS/MS Spectrum - 20V, Positive (Annotated) Predicted LC-MS/MS splash10-0udi-0209000000-6af9d7721225b75d95c7 Predicted MS/MS Spectrum - 20V, Negative (Annotated) Predicted LC-MS/MS splash10-0udi-0209000000-3c32a2c7a486da7be0ad Predicted MS/MS Spectrum - 40V, Positive (Annotated) Predicted LC-MS/MS splash10-0006-0901000000-d4f662611bc1b0a954c5 Predicted MS/MS Spectrum - 40V, Negative (Annotated) Predicted LC-MS/MS splash10-001i-9530000000-fcdf9ec606ff8e8e1743 Predicted 1H NMR Spectrum 1D NMR Not Applicable Predicted 13C NMR Spectrum 1D NMR Not Applicable - Chromatographic Properties
Collision Cross Sections (CCS)
Adduct CCS Value (Å2) Source type Source [M-H]- 157.6218299 predictedDarkChem Lite v0.1.0 [M-H]- 160.41953 predictedDeepCCS 1.0 (2019) [M+H]+ 162.8789501 predictedDarkChem Lite v0.1.0 [M+H]+ 162.77753 predictedDeepCCS 1.0 (2019) [M+Na]+ 173.5716334 predictedDarkChem Lite v0.1.0 [M+Na]+ 168.87067 predictedDeepCCS 1.0 (2019)
Drug created at September 11, 2007 20:02 / Updated at February 21, 2021 18:51